secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2026-05-27T13:00:14+00:00
Accession:  0001493152-26-025340
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma shareholders approve reverse stock split authorization up to 1:150 at annual meeting
--------------------------------------------------------------------------------

- All four director nominees elected with ~2.6M votes each; broker non-votes 582,364.
- Ratification of Forvis Mazars as auditor approved 3,191,174 for, 12,417 against.
- Say-on-pay advisory vote approved 2,650,932 for, 39,906 against.
- Authorization for board to effect reverse stock split (1:2 to 1:150) approved 3,055,436 for, 119,431 against.
- Meeting adjournment proposal also approved 3,077,059 for, though not needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226025340/0001493152-26-025340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226025340/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-025340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer